Cornerstone Wealth Management, LLC Karuna Therapeutics, Inc. Transaction History

Cornerstone Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$93.97 - $143.33 $4,698 - $7,166	-50 Reduced 2.7%	1,805 $228,000
Q1 2022 Apr 21, 2022	SELL	$98.9 - $132.37 $9,890 - $13,237	-100 Reduced 5.12%	1,855 $235,000
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $29,872 - $43,038	-270 Reduced 12.13%	1,955 $272,000
Q2 2021 Aug 09, 2021	SELL	$107.45 - $135.95 $238,539 - $301,809	-2,220 Reduced 49.94%	2,225 $254,000
Q1 2021 Apr 30, 2021	SELL	$95.46 - $133.08 $2,386 - $3,327	-25 Reduced 0.56%	4,445 $534,000
Q4 2020 Jan 29, 2021	BUY	$75.23 - $109.23 $336,278 - $488,258	4,470 New	4,470 $454,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Wealth Management, LLC with notifications on news.